Weekly Update The pandemic spotlight thrusts the ultimate prize into view: an effective vaccine. America’s Moderna and Pfizer are going for gold in the clinical trials marathon alongside a cadre of global health...

Portformer 2.0 – On the Way! Listening to feedback from our loyal advisor community, we’ll soon roll out a new look, enhanced navigation, and expanded functionality like: Replacement Scores with Quarterly...

Investors have sauntered out on the tightrope of the risk curve as the Fed commits to supply liquidity to the markets. While employment numbers bested all expectations, they will likely stay stubbornly high through this...

How well have active managers performed compared to their passive counterparts through COVID-19? And what does this mean for the future of active? Find out in our white paper from new Head of Market of Intelligence...

WEEKLY UPDATE Chairman Powell warned Congress this week of structural damage to the economy and a longer recovery time. As COVID-19 cases creep up through reopening, the market begins to focus on the risk of a...

It was a week of prognostications for restart as caution builds around how anything less than a total recovery in economic activity can be beneficial for us. The concern is concentrated on the potential lingering...

“It’s just the big trying to get even bigger.” Financial giants reared on their hind legs this week in an attempt to position for a shakeup by influencing the reclassification of the risk categories for the ETF...

Does it still hold for this market ? As time goes on, fewer of the historical price anomalies are holding – ”sell in May and go away” has been 50/50 at best. There has been a greater narrative on how to reopen...